Clinical Trial Update: Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating hydroxychloroquine for IgA nephropathy has been registered and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• Hydroxychloroquine (Plaquenil) (hydroxychloroquine)

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: IgA Nephropathy | Phase 2 | Status: NOT_YET_RECRUITING